All posts tagged "FDA Issues Draft Guidance"

FDA CDC News1 year ago

FDA Takes Steps to Advance the Development of Novel Therapies for Stimulant Use Disorders

Currently, there is no FDA-approved medication for stimulant use disorder.
FDA CDC News2 years ago

FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval

The FDA issued draft guidance, Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics, regarding clinical trial design considerations to support accelerated approval applications.

FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval